Hyperkalemia
95
11
15
60
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
28 trials with published results (29%)
Research Maturity
60 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.5%
10 terminated out of 95 trials
85.7%
-0.9% vs benchmark
38%
36 trials in Phase 3/4
47%
28 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 60 completed trials
Clinical Trials (95)
Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study
Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels
Dietary Potassium Liberalization in Pre-Dialysis Patients
Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
Hyperkalemia Quality Improvement Program (HK-QIP) Study
Liberalizing Potassium Restrictions in Patients Receiving Hemodialysis
Potassium Supplementation in CKD
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG
Adding Urea to the Final Dialysis Fluid
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
5 Versus 10 Units of Insulin in Hyperkalemia Management
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
Nurse-Led Nutritional Education for Moroccan Dialysis Patients
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia